AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,093,000 | -54.0% | 160,000 | -45.4% | 0.22% | -56.9% |
| Q4 2017 | $11,081,000 | +52.6% | 293,000 | 0.0% | 0.50% | +50.1% |
| Q3 2017 | $7,263,000 | +20.6% | 293,000 | 0.0% | 0.34% | +10.2% |
| Q2 2017 | $6,024,000 | -5.4% | 293,000 | 0.0% | 0.30% | -17.2% |
| Q1 2017 | $6,367,000 | +6.3% | 293,000 | 0.0% | 0.37% | -8.5% |
| Q4 2016 | $5,992,000 | +36.3% | 293,000 | 0.0% | 0.40% | +45.3% |
| Q3 2016 | $4,395,000 | +38.6% | 293,000 | 0.0% | 0.28% | +17.4% |
| Q2 2016 | $3,170,000 | -20.2% | 293,000 | 0.0% | 0.24% | -29.4% |
| Q1 2016 | $3,973,000 | -17.1% | 293,000 | +12.8% | 0.33% | -8.3% |
| Q4 2015 | $4,790,000 | -5.4% | 259,646 | +29.8% | 0.36% | -11.7% |
| Q3 2015 | $5,064,000 | – | 200,000 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |